{"DataElement":{"publicId":"8178306","version":"1","preferredName":"Anti-Thymocyte Globulin Administered 1 Decimal Place Total Daily Dose","preferredDefinition":"The1 decimal place total daily dose of Anti-Thymocyte Globulin that was administered.","longName":"ATG_TTL_DLY_DOSE","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4182056","version":"1","preferredName":"Anti-Thymocyte Globulin Administered","preferredDefinition":"A purified gamma immunoglobulin (IgG) with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease._The act of having given something (e.g., a medication or test).","longName":"4182054v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4182054","version":"1","preferredName":"Anti-Thymocyte Globulin","preferredDefinition":"A purified gamma immunoglobulin (IgG) with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.","longName":"C278","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-Thymocyte Globulin","conceptCode":"C278","definition":"Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F36A2E6C-D8A3-314A-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2014-02-27","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-02-27","modifiedBy":"ONEDATA","dateModified":"2014-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F36A2E6C-D8B1-314A-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2014-02-27","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-02-27","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8178305","version":"1","preferredName":"1 Decimal Place Total Daily Dose","preferredDefinition":"A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Occurring or done each day._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"8178305v1.0","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mg/kg","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8178309","version":"1","preferredName":"Integer::1 Decimal Place Total Daily Dose","preferredDefinition":"A number with no fractional part, including the negative and positive numbers as well as zero.::1:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:Occurring or done each day.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"8178309v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Daily","conceptCode":"C25473","definition":"Occurring or done each day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBA6A2F-6FA9-0E6C-E053-4EBD850A362F","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-28","modifiedBy":"ONEDATA","dateModified":"2022-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBA124D-5799-7FD0-E053-4EBD850AD8D5","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-28","modifiedBy":"KUMMEROA","dateModified":"2022-08-25","changeDescription":null,"administrativeNotes":"2022.8.25 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the total daily dose","type":"Preferred Question Text","description":"What was the total daily dose of Anti-Thymocyte Globulin that was administered?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Total daily dose of ATG administered:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Total dose of ATG administered during this reporting period:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBA26F3-AF5C-1DDD-E053-4EBD850A7097","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-28","modifiedBy":"KUMMEROA","dateModified":"2022-08-25","changeDescription":null,"administrativeNotes":"2022.8.25 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}